SCHEMBL81359

SCHEMBL81359

O=C(Nc1ccc(N2CCNCC2)cc1)N(c1ccccc1)c1ncc2cn[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 12/20 0.45
CDK2 P24941 2/20 0.45
CDK6 Q00534 2/20 0.45
MAPKAPK2 P49137 1/20 0.40
KDM1A O60341 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ATR Q13535 1/20 0.40
STAT6 P42226 1/20 0.40
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
HTR6 P50406 1/20 0.39
HDAC3 O15379 1/20 0.38
KCNH2 Q12809 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77343 0.90 NPC1 (0.47) FLT3TSHRKDR
SCHEMBL81358 0.86 FLT3 (0.40) FLT3CDK2CDK6MAPKAPK2KDM1A
SCHEMBL80255 0.84 ROCK2 (0.43) FLT3HDAC1
SCHEMBL79583 0.80 RAB9A (0.48)
SCHEMBL79492 0.80 MEN1 (0.41) FLT3ALDH1A1HDAC1
SCHEMBL81868 0.79 L3MBTL1 (0.49) ALDH1A1HDAC3HDAC2
SCHEMBL77813 0.77 RAB9A (0.45) FLT3ALDH1A1TSHRHSD17B10
SCHEMBL78828 0.76 KMT2A (0.38) FLT3HSD17B10HDAC1
SCHEMBL81569 0.76 KDR (0.46) FLT3USP2TSHRKDR
SCHEMBL83675 0.76 CDK2 (0.38) CDK2CDK6USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212333-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS Wyeth LLC (US) 2010-08-04 EP disclosed
WO-2009052145-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS WYETH (US) 2009-04-23 WO disclosed